Natco Pharma informs about Financial Results

12 May 2015 Evaluate

Natco Pharma has informed that a meeting of the Board of Directors of the Company will be held on May 22, 2015, to consider the approval of the unaudited financial Results for the quarter ending March, 2015 along with Audited Annual Accounts for the year 2014-2015, approval of increase of equity investment percentage in the Company to 49% to Foreign Institutional Investors (FIIs) / Foreign Portfolio Investors etc. Further issue of shares or Convertible Securities of any nature in the form of Private Placement, Qualified Institutional Placement (QIP) to Foreign Institutional Investors (FIIs), Qualified Institutional Buyers or any other investors etc, Merger of Natco Organics (100% subsidiary Company) into Natco Pharma, Consideration of Employee Stock Option Scheme under SEBI (Share Based Employee Benefits) Regulations, 2014 and Convening of Extraordinary General Meeting of the Members. Further, TRADING WINDOW for dealing in the securities of the Company will be closed from May 12, 2015 to May 24, 2015. Trading window will be opened from May 25, 2015.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

892.85 -5.95 (-0.66%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×